Investing.com - BioPorto reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
BioPorto announced earnings per share of kr-0.05 on revenue of kr6.50M. Analysts polled by Investing.com EPS of kr-0.06 on revenue of kr6.35M.
BioPorto 's are down 16% and is trading at kr1.474 , still down 64.05% from its 52 week high of kr4.10 set on Wednesday, October 20, 2021.
BioPorto follows other major Healthcare sector earnings this month
BioPorto's report follows an earnings missed by Novo Nordisk B on Thursday, August 4, 2022, who reported EPS of kr5.86 on revenue of kr41.27B, EPS of kr5.96 on revenue of kr41.57B.
Coloplast had missed expectations on Wednesday, August 17, 2022 with third quarter EPS of kr6.14 on revenue of kr5.85B, for EPS of kr6.17 on revenue of kr5.85B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar